Related references
Note: Only part of the references are listed.Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone
Dong-Ho Nam et al.
MOLECULAR HUMAN REPRODUCTION (2007)
In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells
M Zaitseva et al.
MOLECULAR HUMAN REPRODUCTION (2006)
Expression of apoptotic nuclei by ultrastructural terminal deoxyribonucleotidyl transferase mediated dUTP nick end labeling and detection of FasL, caspases and PARP protein molecules in cadmium induced acute alveolar cell injury
KY Kwon et al.
TOXICOLOGY (2006)
Antisense oligonucleotide-based therapeutics for cancer
NM Dean et al.
ONCOGENE (2003)
Reduced hepatic tumor incidence in cyclin G1-deficient mice
MR Jensen et al.
HEPATOLOGY (2003)
Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation
T Ohtsuka et al.
ONCOGENE (2003)
Increased expression of cyclin G1 in leiomyoma compared with normal myometrium
WK Baek et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B′ subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest
DA Bennin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclin G recruits PP2A to dephosphorylate Mdm2
K Okamoto et al.
MOLECULAR CELL (2002)
Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery
SH Kimura et al.
ONCOGENE (2001)
Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1
IJ Moon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
